Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy of oral paroxetine 10 to 40 mg/day (initial
dose:10 mg/day) versus placebo administered once daily (after evening meal) for 8 weeks in
children and adolescents with major depressive disorder (MDD) based on the change from
baseline to Week 8/end-of-study in the CDRS-R total score in a randomized, double-blind,
placebo-controlled parallel-group study.